Time magazine has in recent weeks garnered significant attention from the cancer community.  A lengthy cover story on health care costs by Steven Brill has generated heated discussion among federal policymakers and patient advocates about the problems of American health care spending.  In a more recent edition of Time, Bill Saporito describes a team approach to cancer research in “The Conspiracy to End Cancer.”

Cancer research — indeed, most medical research — is typically about the narrowly focused investigator beavering away, one small grant at a time. But advances in genetic profiling of malignancies and the mutations that cause them are telling scientists and physicians they must stop working in these kinds of silos, treating lung or breast or colon or prostate cancer as distinct diseases. “You no longer do science and medicine differently,” says Dr. Lynda Chin, director of the Institute for Applied Cancer Science at MD Anderson Cancer Center. “It brings science and medicine together.”


Share This Post